TAVI Forum 9

E-mail Print

On Tuesday, October 10, 2023, the Forum for Collaborative Research convened its 9th TAVI Forum meeting at the Revere Hotel Boston Commons in Boston, Massachusetts, USA. The goal of the TAVI Forum is to advance the regulatory sciences for the treatment of TAVI and its associated morbidities by providing an independent and neutral venue for ongoing multi-stakeholder dialogue.

Materials

pdf Agenda

pdf Participant List

Presentations

Introductory Remarks

pdfWelcome and Introduction
Veronica Miller, Forum for Collaborative Research
Per Ljungman, Karolinska University Hospital
Camille Kotton, Massachusetts General Hospital
Shilpa Mitra, Forum for Collaborative Research

Session I: CMV Working Group Updates

pdfCMV Definitions Manuscript
Per Ljungman, Karolinska University Hospital
Roy Chemaly, UT MD Anderson Cancer Center
Camille Kotton, Massachusetts General Hospital
CMV-CMI Project Update
Veronica Miller, Forum for Collaborative Research

Session II: Herpes Simplex Virus

pdfRefractory-Resistant HSV: Proposed Review and Definition
Tali Shafat Fainguelernt, UT MD Anderson Cancer Center
Roy Chemaly, UT MD Anderson Cancer Center

Session III: BKV Working Group Update

pdfProspective Study Strategy
Hannah Imlay, University of Utah
Ajit Limaye, University of Washington
pdfBKV Scientific Advisory Committe
Veronica Miller, Forum for Collaborative Research
pdfBKV Systematic Review and Meta-Analysis
Aasith Villavicencio Paz, University of Miami
Yoichiro Natori, University of Miami/Miami Transplant Institute

Session IV: Adenovirus Working Group Updates

Adenovirus Definitions Update
Brian Fisher, Children’s Hospital of Philadelphia
pdfViral Diagnostics Proposed Meta-Analysis
Veronica Miller, Forum for Collaborative Research
Thomas Lion, LabDia Labordiagnostik GmbH
Per Ljungman, Karolinska University Hospital
Zenia Papanicolaou, Memorial Sloan Kettering Cancer Center

Session V: Human Herpesvirus 6B

pdfDevelopment of Treatment for HHV-6B
Joshua Hill, Fred Hutchinson Cancer Center
Michael Boeckh, Fred Hutchinson Cancer Center

Concluding Remarks

Next Steps
Veronica Miller, Forum for Collaborative Research
Per Ljungman, Karolinska University Hospital
Camille Kotton, Massachusetts General Hospital